AACP
NUVL

Advantage Alpha Capital Partners’s Nuvalent NUVL Stock Holding History

Advantage Alpha Capital Partners’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,851
Closed -$496K – 174
2024
Q3 		$496K Buy
+4,851
New +$402K 0.11% 126

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Advantage Alpha Capital Partners's NUVL Position: Q4 2024 in Review

Advantage Alpha Capital Partners sold out of Nuvalent (NUVL) in Q4 2024, closing a stake of 4,851 shares — an estimated $496K sold.

Advantage Alpha Capital Partners first reported a position in NUVL in Q3 2024 and held it in 1 quarter. The position peaked at $496K in Q3 2024. 216 funds tracked by Wall St. Rank hold NUVL as of Q4 2024.

  • Advantage Alpha Capital Partners reported no remaining Nuvalent position as of Q4 2024 after selling out during the quarter.
  • Advantage Alpha Capital Partners sold 4,851 Nuvalent shares in Q4 2024, an estimated $496K.
  • Advantage Alpha Capital Partners first reported a position in Nuvalent in Q3 2024 and held it in 1 quarter.
  • Advantage Alpha Capital Partners's Nuvalent position peaked at $496K in Q3 2024.
  • 216 funds tracked by Wall St. Rank held Nuvalent as of Q4 2024.

Based on Advantage Alpha Capital Partners's 13F filing for Q4 2024, filed 11 Feb 2025.